Ingvild L. Tangen

2.6k citations

26 papers · 684 indexed · h-index 17

Co-authors: Camilla Krakstad Jone Trovik Helga B. Salvesen Mari K. Halle Anna Berg Erling A. Høivik Kanthida Kusonmano Anne M. Øyan
Topics: Endometrial and Cervical Cancer Treatments (15 papers)Ovarian cancer diagnosis and treatment (11 papers)Estrogen and related hormone effects (5 papers)
Cited by: Obstetrics and Gynecology Reproductive Medicine Cancer Research
Journals: PLoS ONE Scientific Reports Journal of Cell Science
Partner nations: Norway United States Netherlands

In The Last Decade

Ingvild L. Tangen

26 papers receiving 676 citations

Peers

Countries citing papers authored by Ingvild L. Tangen

Since Specialization

Citations

This map shows the geographic impact of Ingvild L. Tangen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingvild L. Tangen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingvild L. Tangen more than expected).

Fields of papers citing papers by Ingvild L. Tangen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingvild L. Tangen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingvild L. Tangen. The network helps show where Ingvild L. Tangen may publish in the future.

Co-authorship network of co-authors of Ingvild L. Tangen

This figure shows the co-authorship network connecting the top 25 collaborators of Ingvild L. Tangen. A scholar is included among the top collaborators of Ingvild L. Tangen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingvild L. Tangen. Ingvild L. Tangen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Nuclear upregulation of class I phosphoinositide 3-kinase p110β correlates with high 47S rRNA levels in cancer cells 2021 ·Journal of Cell Science ·(unknown),Thomas Karlsson,Ingvild L. Tangen,(unknown),(unknown),(unknown),(unknown),(unknown),Camilla Krakstad,Julie Guillermet‐Guibert,Aurélia E. Lewis	6
2	Blood steroid levels predict survival in endometrial cancer and reflect tumor estrogen signaling 2019 ·Gynecologic Oncology ·(unknown),Ingvild L. Tangen,(unknown),Mari K. Halle,Kristin Viste,Bjørg Almås,(unknown),Jone Trovik,Ingfrid S. Haldorsen,Camilla Krakstad	11
3	Plasma growth differentiation factor-15 is an independent marker for aggressive disease in endometrial cancer 2019 ·PLoS ONE ·(unknown),(unknown),Hege F. Berg,Kristine E. Fasmer,Ingvild L. Tangen,Ingfrid S. Haldorsen,Jone Trovik,Camilla Krakstad	7
4	Blood Metabolites Associate with Prognosis in Endometrial Cancer 2019 ·Metabolites ·Elin Strand,Ingvild L. Tangen,Kristine E. Fasmer,(unknown),Mari K. Halle,Erling A. Høivik,Bert Delvoux,Jone Trovik,Ingfrid S. Haldorsen,Andrea Romano,Camilla Krakstad	13
5	Identification of highly connected and differentially expressed gene subnetworks in metastasizing endometrial cancer 2018 ·PLoS ONE ·Kanthida Kusonmano,Mari K. Halle,Elisabeth Wik,Erling A. Høivik,Camilla Krakstad,Karen K. Mauland,Ingvild L. Tangen,Anna Berg,Henrica M.J. Werner,Jone Trovik,Anne M. Øyan,Karl‐Henning Kalland,Inge Jonassen,Helga B. Salvesen,Kjell Petersen	9
6	Blood steroids are associated with prognosis and fat distribution in endometrial cancer 2018 ·Gynecologic Oncology ·Ingvild L. Tangen,Kristine E. Fasmer,(unknown),Arthur Jochems,Bert Delvoux,Sofia Xanthoulea,Tomasz Stokowy,Elin Strand,Hege F. Berg,Seppo Auriola,Jone Trovik,Merja R. Häkkinen,Ingfrid S. Haldorsen,Camilla Krakstad,Andrea Romano	14
7	Clinicopathologic and molecular markers in cervical carcinoma: a prospective cohort study 2017 ·American Journal of Obstetrics and Gynecology ·Mari K. Halle,Akinyemi I. Ojesina,(unknown),Kathrine Woie,Ingvild L. Tangen,Frederik Holst,Erling A. Høivik,Kanthida Kusonmano,Ingfrid S. Haldorsen,Olav Karsten Vintermyr,Jone Trovik,Bjørn I. Bertelsen,Helga B. Salvesen,Camilla Krakstad	40
8	Expression of glucocorticoid receptor is associated with aggressive primary endometrial cancer and increases from primary to metastatic lesions 2017 ·Gynecologic Oncology ·Ingvild L. Tangen,Jennifer Veneris,Mari K. Halle,Henrica M.J. Werner,Jone Trovik,Lars A. Akslen,Helga B. Salvesen,Suzanne D. Conzen,Gini F. Fleming,Camilla Krakstad	18
9	HER2 expression patterns in paired primary and metastatic endometrial cancer lesions 2017 ·British Journal of Cancer ·Mari K. Halle,Ingvild L. Tangen,Hege F. Berg,Erling A. Høivik,Karen K. Mauland,Kanthida Kusonmano,Anna Berg,Antoni Hurtado,Karl‐Henning Kalland,Anne M. Øyan,Ingunn M. Stefansson,Olav Karsten Vintermyr,Henrica M.J. Werner,Ingfrid S. Haldorsen,Jone Trovik,Helga B. Salvesen,Camilla Krakstad	57
10	Preoperative quantitative dynamic contrast-enhanced MRI and diffusion-weighted imaging predict aggressive disease in endometrial cancer 2017 ·Acta Radiologica ·Kristine E. Fasmer,Atle Bjørnerud,Sigmund Ytre‐Hauge,Renate Grüner,Ingvild L. Tangen,Henrica M.J. Werner,Line Bjørge,Øyvind Salvesen,Jone Trovik,Camilla Krakstad,Ingfrid S. Haldorsen	36
11	Asparaginase-like protein 1 is an independent prognostic marker in primary endometrial cancer, and is frequently lost in metastatic lesions 2017 ·Gynecologic Oncology ·(unknown),Hege F. Berg,(unknown),Per‐Henrik Edqvist,(unknown),Anna Berg,Helga B. Salvesen,Lars A. Akslen,Henrica M.J. Werner,Jone Trovik,Ingvild L. Tangen,Camilla Krakstad	16
12	PIK3CA exon9 mutations associate with reduced survival, and are highly concordant between matching primary tumors and metastases in endometrial cancer 2017 ·Scientific Reports ·Siv Mjøs,Henrica M.J. Werner,Even Birkeland,Frederik Holst,Anna Berg,Mari K. Halle,Ingvild L. Tangen,Kanthida Kusonmano,Karen K. Mauland,Anne M. Øyan,Karl‐Henning Kalland,Aurélia E. Lewis,Gordon B. Mills,Camilla Krakstad,Jone Trovik,Helga B. Salvesen,Erling A. Høivik	23
13	Preoperative imaging markers and PDZ-binding kinase tissue expression predict low-risk disease in endometrial hyperplasias and low grade cancers 2017 ·Oncotarget ·Anna Berg,(unknown),Sigmund Ytre‐Hauge,Kristine E. Fasmer,Karen K. Mauland,Erling A. Høivik,J. Husby,Ingvild L. Tangen,Jone Trovik,Mari K. Halle,Ingunn M. Stefansson,Lars A. Akslen,Kathrine Woie,Line Bjørge,Helga B. Salvesen,Øyvind Salvesen,Henrica M.J. Werner,Ingfrid S. Haldorsen,Camilla Krakstad	4
14	Expression of L1CAM in curettage or high L1CAM level in preoperative blood samples predicts lymph node metastases and poor outcome in endometrial cancer patients 2017 ·British Journal of Cancer ·Ingvild L. Tangen,Reidun Kristin Kopperud,Nicole C.M. Visser,Anne Cathrine Staff,Solveig Tingulstad,Janusz Marcickiewicz,Frédéric Amant,Line Bjørge,Johanna M.A. Pijnenborg,Helga B. Salvesen,Henrica M.J. Werner,Jone Trovik,Camilla Krakstad	29
15	Endometrial cancer cells exhibit high expression of p110β and its selective inhibition induces variable responses on PI3K signaling, cell survival and proliferation 2016 ·Oncotarget ·Thomas Karlsson,Camilla Krakstad,Ingvild L. Tangen,Erling A. Høivik,Pamela M. Pollock,Helga B. Salvesen,Aurélia E. Lewis	11
16	Androgen receptor as potential therapeutic target in metastatic endometrial cancer 2016 ·Oncotarget ·Ingvild L. Tangen,(unknown),Reidun Kopperud,Anna Berg,Mari K. Halle,Anne M. Øyan,Henrica M.J. Werner,Jone Trovik,Karl‐Henning Kalland,Helga B. Salvesen,Camilla Krakstad	56
17	Stathmin Protein Level, a Potential Predictive Marker for Taxane Treatment Response in Endometrial Cancer 2014 ·PLoS ONE ·Henrica M.J. Werner,Jone Trovik,Mari K. Halle,Elisabeth Wik,Lars A. Akslen,Even Birkeland,(unknown),Ingvild L. Tangen,Camilla Krakstad,Helga B. Salvesen	34
18	Loss of progesterone receptor links to high proliferation and increases from primary to metastatic endometrial cancer lesions 2014 ·European Journal of Cancer ·Ingvild L. Tangen,Henrica M.J. Werner,Anna Berg,Mari K. Halle,Kanthida Kusonmano,Jone Trovik,Erling A. Høivik,Gordon B. Mills,Camilla Krakstad,Helga B. Salvesen	61
19	High level of HSF1 associates with aggressive endometrial carcinoma and suggests potential for HSP90 inhibitors 2014 ·British Journal of Cancer ·(unknown),Ingvild L. Tangen,Sören Berg,Kanthida Kusonmano,Mari K. Halle,Anne M. Øyan,Karl‐Henning Kalland,Ingunn M. Stefansson,Jone Trovik,Helga B. Salvesen,Camilla Krakstad	49
20	Switch in FOXA1 Status Associates with Endometrial Cancer Progression 2014 ·PLoS ONE ·Ingvild L. Tangen,Camilla Krakstad,Mari K. Halle,(unknown),Anne M. Øyan,Kanthida Kusonmano,Kjell Petersen,Karl‐Henning Kalland,Lars A. Akslen,Jone Trovik,Antoni Hurtado,Helga B. Salvesen	20

About Ingvild L. Tangen

Ingvild L. Tangen is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Equine, having authored 26 papers that have together received 684 indexed citations. Recurring topics across this work include Endometrial and Cervical Cancer Treatments (15 papers), Ovarian cancer diagnosis and treatment (11 papers) and Estrogen and related hormone effects (5 papers). The work is most often cited by research in Obstetrics and Gynecology (326 citations), Reproductive Medicine (200 citations) and Cancer Research (145 citations). Ingvild L. Tangen has collaborated with scholars based in Norway, United States and Netherlands. Frequent co-authors include Camilla Krakstad, Jone Trovik, Helga B. Salvesen, Mari K. Halle, Anna Berg, Erling A. Høivik, Kanthida Kusonmano, Anne M. Øyan, Ingfrid S. Haldorsen and Henrica M.J. Werner. Their work appears in journals such as PLoS ONE, Scientific Reports and Journal of Cell Science.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact